Long-Term Combined Training in Idiopathic Pulmonary Fibrosis: A Case Study

被引:7
|
作者
Naranjo-Orellana, Jose [1 ]
Santalla, Alfredo [1 ,2 ]
机构
[1] Pablo de Olavide Univ, Dept Sport & Comp, Seville 41013, Spain
[2] Inst Invest Hosp 12 Octubre I 12, Madrid 28041, Spain
关键词
inspiratory muscle training; resistance training; idiopathic pulmonary fibrosis; LUNG TRANSPLANTATION; INSPIRATORY MUSCLE; VENTILATORY EFFICIENCY; ARTERIAL-HYPERTENSION; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; REHABILITATION; BENEFITS; OUTCOMES;
D O I
10.3390/ijerph17145091
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A supervised combined training program was applied to a sedentary 56-year-old man with idiopathic pulmonary fibrosis (IPF) along three years, until lung transplantation. It included: (a) aerobic continuous (CT) and interval training (IT), (b) high load resistance training (RT) and (c) inspiratory muscle training (IMT). IT and IMT were applied for two years, while CT and RT could be maintained until transplantation using supplemental oxygen. Maximal inspiratory pressure (MIP) kept above 180 cm H2O and forced vital capacity (FVC) remained stable until lung transplantation. Peak oxygen uptake VO(2)increased during 1.5 years before its decline, staying above the poor prognosis level two years. Finally, the patient maintained his walking capacity and independence for 2 years, before the decline due to the disease. After receiving a two-lung transplant, the patient remained intubated for 12 h, left the intensive care unit after 3.5 days and was discharged after 18 days (average values: 48 h, 7-10 days and 25-35 days, respectively). These results show that systematic and supervised combined training can be safety applied in an IPF patient to maintain functionality and quality of life. In addition, we show that RT can be maintained for as long as necessary without complications.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [21] Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
    Tomos, Ioannis
    Dimakopoulou, Konstantina
    Manali, Effrosyni D.
    Papiris, Spyros A.
    Karakatsani, Anna
    ENVIRONMENTAL HEALTH, 2021, 20 (01)
  • [22] Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
    Ioannis Tomos
    Konstantina Dimakopoulou
    Effrosyni D. Manali
    Spyros A. Papiris
    Anna Karakatsani
    Environmental Health, 20
  • [23] Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival
    Tanaka, Shin
    Miyoshi, Kentaroh
    Higo, Hisao
    Kurosaki, Takeshi
    Otani, Shinji
    Sugimoto, Seiichiro
    Yamane, Masaomi
    Kiura, Katsuyuki
    Toyooka, Shinichi
    Oto, Takahiro
    RESPIRATORY INVESTIGATION, 2019, 57 (02) : 165 - 171
  • [24] Lung Cancer in Patients With Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmonary Fibrosis. A Descriptive Study in a Spanish Series
    Portillo, Karina
    Perez-Rodas, Nancy
    Garcia-Olive, Ignasi
    Guasch-Arriaga, Ignasi
    Centeno, Carmen
    Serra, Pere
    Becker-Lejuez, Caroline
    Sanz-Santos, Jose
    Andreo Garcia, Felip
    Ruiz-Manzano, Juan
    ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (06): : 304 - 310
  • [25] Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis
    Antoniou, K. M.
    Nicholson, A. G.
    Dimadi, M.
    Malagari, K.
    Latsi, P.
    Rapti, A.
    Tzanakis, N.
    Trigidou, R.
    Polychronopoulos, V.
    Bouros, D.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (03) : 496 - 504
  • [26] Long-term outcomes of antifibrotic treatments in patients with idiopathic pulmonary fibrosis: Real-world experience
    Nayci, Sibel
    Polat, Demet
    Ozgur, Eylem Sercan
    Ozge, Cengiz
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [27] Long term survival of advanced hepatoid adenocarcinoma of lung secondary to idiopathic pulmonary fibrosis: a case report
    Wang, Xiaoli
    Wei, Nan
    Yang, Huizhen
    Wang, Xiaoyan
    Zhang, Xiaoju
    Zhang, Qianqian
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [28] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [29] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [30] Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
    Cameli, Paolo
    Refini, Rosa Metella
    Bergantini, Laura
    d'Alessandro, Miriana
    Alonzi, Valerio
    Magnoni, Carlo
    Rottoli, Paola
    Sestini, Piersante
    Bargagli, Elena
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7